Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs.

BMC Medicine
Thomas BurnettThomas Jaki

Abstract

Adaptive designs for clinical trials permit alterations to a study in response to accumulating data in order to make trials more flexible, ethical, and efficient. These benefits are achieved while preserving the integrity and validity of the trial, through the pre-specification and proper adjustment for the possible alterations during the course of the trial. Despite much research in the statistical literature highlighting the potential advantages of adaptive designs over traditional fixed designs, the uptake of such methods in clinical research has been slow. One major reason for this is that different adaptations to trial designs, as well as their advantages and limitations, remain unfamiliar to large parts of the clinical community. The aim of this paper is to clarify where adaptive designs can be used to address specific questions of scientific interest; we introduce the main features of adaptive designs and commonly used terminology, highlighting their utility and pitfalls, and illustrate their use through case studies of adaptive trials ranging from early-phase dose escalation to confirmatory phase III studies.

References

May 1, 1974·Clinical Pharmacology and Therapeutics·D R Taves
Mar 26, 1999·Journal of Biopharmaceutical Statistics·J O'QuigleyA Gamst
Dec 28, 1999·Statistics in Medicine·D M ZuckerE Brittain
Jul 6, 2000·Biometrics·M Gasparini, J Eisele
Jul 6, 2001·Statistics in Medicine·J S Babb, A Rogatko
Jan 5, 2002·Biometrics·J O'QuigleyT Fenton
Dec 31, 2002·Controlled Clinical Trials·Neil W ScottMarion K Campbell
Feb 15, 2003·Statistics in Medicine·Nigel Stallard, Susan Todd
Nov 7, 2003·Biometrics·Peter F ThallSang-Joon Lee
Nov 7, 2003·Biometrics·Linda M HainesWilliam F Rosenberger
Dec 4, 2003·Statistics in Medicine·Meinhard Kieser, Tim Friede
Feb 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jonathan D ChengAndré Rogatko
Mar 2, 2005·Biometrics·Kai Wang, Anastasia Ivanova
Apr 9, 2005·BMJ : British Medical Journal·Douglas G Altman, J Martin Bland
Jul 19, 2005·Journal of Biopharmaceutical Statistics·Shein-Chung ChowAnnpey Pong
Aug 2, 2005·Biometrical Journal. Biometrische Zeitschrift·Allan R Sampson, Michael W Sill
Sep 1, 2005·Statistics in Medicine·John M Lachin
Oct 12, 2005·Statistics in Medicine·Thomas M Braun
Oct 21, 2005·Contemporary Clinical Trials·J C DumvilleD J Torgerson
Nov 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Boris Freidlin, Richard Simon
Jan 26, 2006·British Journal of Cancer·J O'Quigley, S Zohar
Jun 3, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Xavier PaolettiRichard Sylvester
Sep 14, 2006·Statistics in Medicine·Sarah Zohar, John O'Quigley
Sep 16, 2006·Biometrical Journal. Biometrische Zeitschrift·Tim Friede, Meinhard Kieser
Sep 16, 2006·Biometrical Journal. Biometrische Zeitschrift·Frank BretzWilli Maurer
Sep 16, 2006·Biometrical Journal. Biometrische Zeitschrift·Heinz SchmidliWilli Maurer
Sep 16, 2006·Biometrical Journal. Biometrische Zeitschrift·Christopher Jenniso, Bruce W Turnbull
Oct 4, 2006·Statistics in Medicine·Sumithra J MandrekarDaniel J Sargent
Nov 4, 2006·Pharmaceutical Statistics·Sarah Zohar, John O'Quigley
Nov 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·André RogatkoAlan Porter
Jun 19, 2008·Clinical Trials : Journal of the Society for Clinical Trials·Xian ZhouJ Jack Lee
Jul 12, 2008·Statistics in Medicine·Ying Yuan, Guosheng Yin
Aug 30, 2008·Journal of the National Cancer Institute·Mahesh K B ParmarPatrick Royston
Oct 2, 2008·Clinical Trials : Journal of the Society for Clinical Trials·Alexia IasonosDavid R Spriggs

❮ Previous
Next ❯

Citations

Mar 7, 2021·International Journal of Molecular Sciences·Jilly Frances EvansVera P Krymskaya
Oct 2, 2021·BMJ : British Medical Journal·Kathryn SkivingtonLaurence Moore
Oct 27, 2021·Multiple Sclerosis : Clinical and Laboratory Research·Louis Poncet-MegemontXavier Moisset

❮ Previous
Next ❯

Software Mentioned

MAMS
TAPPAS
Practical Adaptive and Novel Designs and Analysis ( PANDA ) to...
nStage
TAILoR
R
R package ‘ bandit
DESMA
ELEFANT
gsDesign

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.